Zolgensma Continues to Prevent Motor Function Decline for 5 Years

SMA News Today’s multimedia associate, Price Wooldridge, discusses how Zolgenzma continues to prevent motor function decline for five years for patients with Spinal Muscular Atrophy (SMA).Also, SMA News Today content creator DeAnn Runge talks about how justifying our needs has become second nature. She discusses how she’s appealing a denial for the Jaco Robotic Arm as well as other hoops she has to jump through to remain living her life.Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/